This is particularly advantageous for large circuits, where dosage or part changes require extensive re-cloning of plasmids for cellular testing, but no additional time for in vitro testing.
To use the comet assay for cellular chemosensitivity testing of other chemotherapeutics, like oxazophosphorines, nitrosoureas, actinomycin D, or mitomycin C, it is at first necessary to verify the positive correlation between cyto- and genotoxicity for each compound, individually, as shown here for cis- and carboplatin.
However, closely related SUT/SUC proteins in different species can localize to different membranes [ 57] and, indeed, they may change their location in order to drive particular cellular processes; direct testing of cellular location would therefore be required for the cotton fibre homologs.
The approach enables the testing of cellular responses to individual signaling molecules as well as their spatial ordering.
A cellular system for experimental testing of the inhibitors was also established by expressing wildtype and internal tandem duplication mutant FLT3 (FLT3-WT and FLT3-ITD) in FDC-P1 cells.
For the testing of cellular cytotoxicity of empty nanoparticles, they were diluted with serum-free RPMI1640 media and sterilized with a 0.8-μm syringe filter and added to 2 × 104 Hcells cells.
As such, it can represent a useful model for preclinical testing of cellular populations and stem cell-derived cardiomyocytes for tissue engineering.
Furthermore, testing of cellular antioxidant protection using the CAP-e assay showed that NAE-8® contains more antioxidants that are bioavailable at the cellular level, compared to AQ-NOE.
This approach is very powerful, since it enables the testing of cellular responses to individual cRGD nanopatches and their spatial ordering which is very important for comparing the impact of different ligands for integrin activation as reported here.
